Bacterial inflammation.

被引:1
作者
Cavaillon, JM
机构
来源
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE | 1996年 / 36卷 / 08期
关键词
D O I
10.1016/S0335-7457(96)80112-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Bacterial inflammation, initiated by microbial products themselves, plays an essential role in the efficacy of the host's response to infection. Natural antiinfectious immunity requires the participation of many cells and cytokines involved in the installation of the antibacterial response and in the inflammatory response. Among the numerous surface constituents and soluble factors released by bacteria, Gram negative bacterial endotoxins and Gram positive bacterial exotoxins play a predominant role by their capacity to induce the production of various cytokines. The inflammatory response, initiated in this way, requires a harmonious balance between pro-inflammatory factors and factors responsible for limiting the inflammatory process. Cells of the immune system are obviously an important source of these cytokines, but other cells such as mast cells also play a decisive role. Phagocytic cells activated by cytokines contribute to the elimination of pathogens via their increased microbicidal activity while also contributing to maintenance of the inflammatory process via the release of various pro-inflammatory mediators. Exacerbation of the production of certain cytokines is probably responsible for the tissue damage which on accompany infections. However, the extraordinary adaptation capacity of bacteria which allows them to thwart the mechanisms designed to eliminate them, can Limit the impact of the anti-infectious process.
引用
收藏
页码:914 / 924
页数:11
相关论文
共 36 条
[1]   STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS [J].
ADERKA, D ;
ENGELMANN, H ;
MAOR, Y ;
BRAKEBUSCH, C ;
WALLACH, D .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :323-329
[2]  
BARBER AE, 1993, J IMMUNOL, V150, P1999
[3]   BACTERIAL EVASION OF HOST IMMUNE DEFENSE - YERSINIA-ENTEROCOLITICA ENCODES A SUPPRESSOR FOR TUMOR-NECROSIS-FACTOR-ALPHA EXPRESSION [J].
BEUSCHER, HU ;
RODEL, F ;
FORSBERG, A ;
ROLLINGHOFF, M .
INFECTION AND IMMUNITY, 1995, 63 (04) :1270-1277
[4]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[5]   MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71
[6]   THE NONSPECIFIC NATURE OF ENDOTOXIN TOLERANCE [J].
CAVAILLON, JM .
TRENDS IN MICROBIOLOGY, 1995, 3 (08) :320-324
[7]   STIMULATORY AND INHIBITORY EFFECTS OF INTERLEUKIN (IL)-4 AND IL-13 ON THE PRODUCTION OF CYTOKINES BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - PRIMING FOR IL-12 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION [J].
DANDREA, A ;
MA, XJ ;
ASTEAMEZAGA, M ;
PAGANIN, C ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :537-546
[8]   SHOCK AND MULTIPLE-ORGAN DYSFUNCTION AFTER SELF-ADMINISTRATION OF SALMONELLA ENDOTOXIN [J].
DASILVA, AMT ;
KAULBACH, HC ;
CHUIDIAN, FS ;
LAMBERT, DR ;
SUFFREDINI, AF ;
DANNER, RL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (20) :1457-1460
[9]   INTERLEUKIN-4 AND INTERLEUKIN-10 INCREASE ENDOTOXIN-STIMULATED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELL INTERLEUKIN-8 RELEASE [J].
DEBEAUX, AC ;
MAINGAY, JP ;
ROSS, JA ;
FEARON, KCH ;
CARTER, DC .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (05) :441-445
[10]   INTERLEUKIN-6 IS USED AS A GROWTH-FACTOR BY VIRULENT MYCOBACTERIUM-AVIUM - PRESENCE OF SPECIFIC RECEPTORS [J].
DENIS, M .
CELLULAR IMMUNOLOGY, 1992, 141 (01) :182-188